Interestingly, although IL-6 is a well-established driver of RA pathogenesis, one study found that TNF-α siRNA and IL-1β siRNA produced more pronounced therapeutic effects in collagen-induced arthritis (CIA) mice compared to IL-6 siRNA, underscoring the importance of target selection and disease context (44). The gene discussed is IL6; the disease is rheumatoid arthritis.